Third vaccine for influenza pandemic (H1N1) 2009
The European Commission has yesterday, following the positive scientific opinion issued on 1st October by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA), authorised a third vaccine for the influenza pandemic, Celvapan® (Baxter).
|